Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications

The direction comes against reports of global shortages of the critical drug. Remdesivir is considered as a key antiviral drug in the fight against COVID-19, especially in adult patients with severe complications.

The new wave came as a surprise after production was not continued as many countries were more focused on vaccination.

The countries such as Venezuela has decided to procure remdesivir injections from Indian firms who can export, so that they could be provided treatment of critical COVID-19 patients from the economically weaker sections.